Target intelligence / Profile preview

Phosphate carrier protein, mitochondrial (SLC25A3)

Target
SLC25A3
Molecular classification
Transporter (specifically, mitochondrial inner membrane transporter), Mitochondrial carrier family (SLC25 family)
01

Overview

The phosphate carrier protein, mitochondrial (SLC25A3), is a multi-pass transmembrane transporter located in the inner mitochondrial membrane and belongs to the mitochondrial carrier family (SLC25)[1][5][7]. Its principal function is to import inorganic phosphate (Pi) into the mitochondrial matrix, which is essential for ATP production via oxidative phosphorylation[1][5][6]. SLC25A3 is also involved in mitochondrial copper transport, necessary for the activity of cytochrome c oxidase and thus for respiratory chain function[2][3][4]. There are two major isoforms, resulting from alternative splicing, with tissue-specific distribution (cardiac/skeletal muscle vs. ubiquitous)[2][3][5]. Mutations in SLC25A3 cause a severe, often fatal disorder characterized by lactic acidosis, hypotonia, cardiomyopathy, and early death[5][6]. Beyond energy metabolism, SLC25A3 regulates mitochondrial membrane potential, affects susceptibility to cell death via regulation (not direct formation) of the mitochondrial permeability transition pore, and plays a role in mitochondrial calcium homeostasis[1][6]. No approved drugs directly target SLC25A3, but it represents a potential therapeutic target for mitochondrial and metabolic diseases[1][6].

Other names
Solute carrier family 25 member 3SLC25A3Phosphate transport protein, mitochondrialPhosphate carrier (PHC)PiC2, PiCPTPOK/SW-cl.48
02

Mechanism of action

Not applicable for approved drugs, but research compounds indirectly modulate carrier activity, mitochondrial permeability, or metabolic flux through SLC25A3 in experimental models.

03

Biological functions

Phosphate transport into the mitochondrial matrix, which is essential for oxidative phosphorylation and ATP synthesisCopper transport (recent evidence shows SLC25A3 can also transport copper, impacting cytochrome c oxidase activity)Regulation of mitochondrial calcium handlingModulation of mitochondrial permeability transition pore (MPTP) activity (implicated in cell death pathways; not a direct pore component but a regulator)
04

Disease associations

Mitochondrial phosphate carrier deficiency (a fatal disorder in children; characterized by lactic acidosis, hypertrophic cardiomyopathy, hypotonia)Cardiomyopathy (congenital or acquired form, especially hypertrophic cardiomyopathy)Muscle hypotoniaLactic acidosis (in the context of metabolic/energy deficiencies)Other (broad mitochondrial dysfunctions; some evidence implicates roles in apoptosis susceptibility in certain settings)
05

Safety considerations

Loss-of-function mutations are associated with fatal infantile disease, severe lactic acidosis, cardiomyopathy, and myopathyTargeting could impact fundamental energy metabolism, leading to cardiac, muscular, and neurological side effectsPotential for mitochondrial toxicity if transporter function is impaired
06

Interacting drugs

Currently, no specific approved drugs directly target SLC25A3 in therapy, but small molecules like bongkrekic acid and analogs are used experimentally to investigate function and conformation in the ADP/ATP carrier, another SLC25 member. No direct clinical use established for SLC25A3-specific ligands.
07

Biomarkers

SLC25A3 gene mutations serve as biomarkers for mitochondrial phosphate carrier deficiency and cardiomyopathyAltered SLC25A3 expression or function could be explored as a biomarker for mitochondrial disease diagnostics and perhaps for assessing certain metabolic syndromes

Beyond the preview

Go deeper on Phosphate carrier protein, mitochondrial (SLC25A3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphate carrier protein, mitochondrial (SLC25A3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call